La obesidad es un gran desafo global que la OMS est comprometida a abordar apoyando a pases y personas para controlarla de manera efectiva y equitativa
K., Brzezik, J., Madra-Gackowska, K., & Szeleszczuk, L
Status: Terminated
From increased energy to improved recovery and long-term wellness goals, this conversation explores what individualized care can look like in real life and why one-size-fits-all solutions dont work for everyone
At week 24, apitegromab resulted in a least square mean (80% confidence interval (CI)) of 1.9 (1.22.7) kg less lean mass loss than placebo ( P = 0.001), despite similar total body weight loss between groups, representing a 54.9% retention of lean mass relative to placebo
Avoid mixing with alcohol or liver-affecting medications.